Characterisation of a musculoskeletal syndrome of enthesitis and arthritis in patients with Atopic Dermatitis treated with Dupilumab, an IL-4/13 inhibitor.

Catherine D Hughes, Joseph Nathan, Libin Mathew,Andrew E Pink, Richard T Woolf,Catherine Smith, Bina Menon,Bruce Kirkham

Arthritis & rheumatology (Hoboken, N.J.)（2023）

引用 0|浏览13

暂无评分

摘要

We report a new MSK syndrome of inflammatory enthesitis/arthritis/tenosynovitis in some patients receiving the IL-4 Receptor antagonist, dupilumab. This response to a cytokine-targeted therapy provides key insights into the pathogenesis of enthesitis. This article is protected by copyright. All rights reserved.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要